Comparing clinical outcomes in patients with type 2 diabetes mellitus after ischaemic stroke: Sodium-glucose cotransporter 2 inhibitors users versus non-users. A propensity score matching National Cohort Study.
Tzu-Yang ChenHsin-Fu LeeYi-Hsin ChanChi ChuangPei-Ru LiYung-Hsin YehHung-Chi SuLai-Chu SeePublished in: Diabetes, obesity & metabolism (2024)
Our findings indicate significantly lower risks of recurrent IS and all-cause mortality among patients with T2DM receiving SGLT2i treatment. Further studies are required to validate these results and investigate the underlying mechanisms behind the observed effects.